To view the PDF file, sign up for a MySharenet subscription.

LABAT AFRICA LIMITED - Agreement to Issue Shares for Cash to Verityhurst (Pty) Ltd and Extension of Bookbuild Closing Date

Release Date: 26/06/2020 17:03
Code(s): LAB     PDF:  
Wrap Text
Agreement to Issue Shares for Cash to Verityhurst (Pty) Ltd and Extension of Bookbuild Closing Date

LABAT AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1986/001616/06)
(“Labat Africa” or “the Company”)
ISIN Code: ZAE 000018354 Share code: LAB


AGREEMENT TO ISSUE SHARES FOR CASH TO VERITYHURST PROPRIETARY LIMITED
("VERITYHURST”) AND EXTENSION OF BOOKBUILD CLOSING DATE



1.   Introduction
     Shareholders are referred to the announcement released on the Stock Exchange
     News Service (“SENS”) on 5 May 2020 relating to the Company’s intention to raise up
     to R112 million through the issue of shares by way of a bookbuild (the “Bookbuild”)
     under and in accordance with the Company’s existing General Authority to issue
     share for cash granted by shareholders at the annual general meeting held on
     17 March 2020 (“General Authority”).

     The Board is pleased to announce that the Company has entered into a share
     subscription agreement with Verityhurst (“Share Subscription Agreement”) in terms of
     which Verityhurst has agreed to subscribe for up to 70 000 000 ordinary shares in
     Labat (“Subscription Shares”) for cash in two separate and divisible tranches.

2    Subscription
     In term of the Share Subscription Agreement, Verityhurst will subscribe for up to
     40 000 000 ordinary shares (“Tranche 1 Subscription Shares”) on or before 10 July 2020
     (“Tranche 1 Subscription Effective Date”) at a subscription price of 50 (fifty) cents per
     share (“Tranche 1 Subscription Consideration”) for a total consideration of
     R20 000 000 and will thereafter subscribe for a further 30 000 000 ordinary shares
     (“Tranche 2 Subscription Shares”) on or before 31 August 2020 (“Tranche 2
     Subscription Effective Date”) at a subscription price of R1.00 per share (“Tranche 2
     Subscription Consideration”). The issue of shares will be at a premium to the 30-day
     Volume-Weighted-Average Price prior to the board approval of the General
     Authority to issue shares for cash.

     The Company shall obtain approval from the JSE for the listing of the Tranche 1
     Subscription shares and the Tranche 2 Subscription Shares as soon as possible after
     receipt of written confirmation that the respective consideration has been received
     into its bank account. Notwithstanding this, should less than the full Tranche 1
     Subscription Consideration be received by the Company by the Tranche 1
     Subscription Effective Date or less than the full Tranche 2 Subscription Consideration
     by the Tranche 2 Subscription Effective Date, then the Company shall apply to list
     such number of shares at 50 cents per ordinary share up to R20 000 000 and such
     number of shares at R1.00 per ordinary share, calculated based on the cash received
     by the Company.

3.   Intended use of funds
     The Company will use the proceeds of the Subscription Shares for the capital
     expenditure and working capital requirements relating to its medical cannabis and
     industrial hemp strategic initiatives.

4.   Extension of Bookbuild
     In light of the interest received by the Company for the Bookbuild and presentations
     still ongoing due to COVID-19, the Board has elected to extend the date of the
     Bookbuild to 31 August 2020 or such earlier date once the full funding has been
     raised.

Johannesburg
26 June 2020

Designated Advisor
Arbor Capital Sponsors

Date: 26-06-2020 05:03:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story